Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05565417
Title	Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
Recruitment	Recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Immunitas Therapeutics
Indications	Burkitt lymphoma colorectal cancer small intestine carcinoma estrogen-receptor positive breast cancer progesterone-receptor positive breast cancer skin squamous cell carcinoma head and neck squamous cell carcinoma esophageal cancer triple-receptor negative breast cancer Hodgkin's lymphoma diffuse large B-cell lymphoma adult T-cell leukemia/lymphoma lung non-small cell carcinoma
Therapies	IMT-009
Age Groups:	adult \| senior
Covered Countries	USA